SIC
LENZ

SJS Investment Consulting’s LENZ Therapeutics LENZ Stock Holding History

SJS Investment Consulting’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$319 Buy
56
+45
+409% +$363 ﹤0.01% 2381
2026
Q1 		$101 Buy
+11
New +$155 ﹤0.01% 2132

Other funds holding LENZ

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
BL
BFSG LLC Irvine, California $1.13B AUM 29.95% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

SJS Investment Consulting's LENZ Position: Q2 2026 in Review

SJS Investment Consulting increased its LENZ Therapeutics (LENZ) stake by 409% in Q2 2026, buying an estimated $363 and bringing the position to 56 shares worth $319. The position accounts for ﹤0.01% of the portfolio, ranked #2381.

SJS Investment Consulting first reported a position in LENZ in Q1 2026 and has held it in 2 quarters since. 21 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • SJS Investment Consulting held 56 shares of LENZ Therapeutics worth $319 as of Q2 2026.
  • SJS Investment Consulting bought 45 LENZ Therapeutics shares in Q2 2026, an estimated $363.
  • LENZ Therapeutics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2381 holding.
  • SJS Investment Consulting first reported a position in LENZ Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 21 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.